Has Kevin Lawson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,191 in general payments to Kevin Lawson, MD across 57 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kevin Lawson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kevin Lawson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kevin Lawson, MD

Orthopaedic Surgery · Stanford, CANPI 1962815886

Payments from drug & device makers

$4,191in general payments, 2019–2025

Across 57 payments — averaging $73.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Zimmer Biomet$2K
Summit Surgical Corp.$741
Medical Device Business Services, Inc.$295
Smith+Nephew$183
BD$142
Heron Therapeutics, Inc.$119
plus $236 from 4 others

What the payments were for

Travel & lodging$1,05325%
Food & beverage$1,77342%
Education$1,36533%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Zimmer Biomet	40	$2,474
Summit Surgical Corp.	1	$741
Medical Device Business Services, Inc.	2	$295
Smith+Nephew	3	$183
BD	1	$142
Heron Therapeutics, Inc.	2	$119
Johnson & Johnson(2 entities)	3	$78
Microport Orthopedics Inc	1	$67
Invictus Surgical Incorporated	1	$48
Merck	3	$42

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,191 in reported general payments places this provider in the 55th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024

$172,921

Medicare patients

238

Services billed

5,040

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	91	$1,499
Cyclobenzaprine Hcl	40	$291
Meloxicam	25	$46
Amoxicillin	14	$10

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Stanford

Ariel PalancaStanford$633K
Bradford HackArcadia$18.3M
Robert GorabOrange$14.5M
Kelly VinceLos Angeles$9.6M
Stephen HowellSacramento$9.4M
Thomas CoonRed Bluff$9.2M
Peter NewtonSan Diego$7M
Nirav AminPlacentia$5.8M
Tom NorrisSan Francisco$5.3M
Jay LiebermanLos Angeles$4.8M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →